NSAIDs suppress the expression of claudin-2 to promote invasion activity of cancer cells

Carcinogenesis

Volumn 29, Issue 10, 2008, Pages 1994-2000

  Mima, Shinji ^a   Takehara, Masaya ^a   Takada, Hiroko ^a   Nishimura, Tomoko ^a   Hoshino, Tatsuya ^a   Mizushima, Tohru ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CLAUDIN 2; DICLOFENAC; IBUPROFEN; INDOMETACIN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CELL GROWTH; CELL MIGRATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; CALCIUM; CELL LINE, TUMOR; CELL MOVEMENT; CYCLOOXYGENASE INHIBITORS; HUMANS; INDOMETHACIN; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; RNA, MESSENGER;

EID: 53349160180     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn134     Document Type: Article

References (39)

1. Wang,W.H. et al. (2003) Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: A systematic review and meta-analysis. J. Natl Cancer Inst., 95, 1784-1791.
2. Hoshino,T. et al. (2003) Prostaglandin E2 Protects Gastric Mucosal Cells from Apoptosis via EP2 and EP4 Receptor Activation. J. Biol. Chem., 278, 12752-12758.
3. Rolland,P.H. et al. (1980) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. J. Natl Cancer Inst., 64, 1061-1070.
4. Tsujii,M. et al. (1998) Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. Cell, 93, 705-716.
5. Eberhart,C.E. et al. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188.
6. Ristimaki,A. et al. (1997) Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57, 1276-1280.
7. Piazza,G.A. et al. (1997) Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res., 57, 2909-2915.
8. Reddy,B.S. et al. (1999) Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process. Cancer Res., 59, 3387-3391.
9. Mima,S. et al. (2005) Induction of claudin-4 by nonsteroidal anti-inflammatory drugs and its contribution to their chemopreventive effect. Cancer Res., 65, 1868-1876.
10. Anderson,J.M. et al. (1995) Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J. Physiol. 269, G467-G475.
11. Tsukita,S. et al. (2001) Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol., 2, 285-293.
12. Morin,P.J. (2005) Claudin proteins in human cancer: Promising new targets for diagnosis and therapy. Cancer Res., 65, 9603-9606.
13. Swisshelm,K. et al. (2005) Role of claudins in tumorigenesis. Adv. Drug Deliv. Rev., 57, 919-928.
14. Agarwal,R. et al. (2005) Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res., 65, 7378-7385.
15. Dhawan,P. et al. (2005) Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J. Clin. Invest., 115, 1765-1776.
16. Michl,P. et al. (2003) Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res., 63 6265-6271.
17. Miyamori,H. et al. (2001) Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J. Biol. Chem., 276, 28204-28211.
18. Oku,N. et al. (2006) Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res., 66 5251-5257.
19. Amasheh,S. et al. (2002) Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J. Cell Sci., 115, 4969-4976.
20. Furuse,M. et al. (2001) Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J. Cell Biol., 153, 263-272.
21. Kinugasa,T. et al. (2000) Cloning of the human claudin-2 5′-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. Gastroenterology, 118, 1001-1011.
22. Mankertz,J. et al. (2004) Claudins regulate the intestinal barrier in response to immune mediators. Biochem. Biophys. Res. Commun., 314, 1001-1007.
23. Sakaguchi,T. et al. (2002) Functional crosstalk between Wnt signaling and Cdx-related transcriptional activation in the regulation of the claudin-2 promoter activity. J. Biol. Chem., 277, 21361-21370.
24. Tsutsumi,S. et al. (2002a) Transforming Growth Factor-beta-1 Is Responsible for Maturation-Dependent Spontaneous Apoptosis of Cultured Gastric Pit Cells. Exp. Biol. Med. (Maywood), 227, 402-411.
25. Mullin,J.M. et al. (2005) Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes. Mol. Biol. Cell, 16, 5538-5550.
26. Osanai,M. et al. (2006) Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res., 66, 9125-9133.
27. Larkins,T.L. et al. (2006) Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer, 6, 181.
28. Wittchen,E.S. et al. (2003) NZO-3 expression causes global changes to actin cytoskeleton in Madin-Darby canine kidney cells: Linking a tight junction protein to Rho GTPases. Mol. Biol. Cell, 14, 1757-1768.
29. Lim,J.W. et al. (2001) Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells. Lab. Invest., 81, 349-360.
30. Tsuji,S. et al. (1996) Evidences for involvement of cyclooxygenase-2 in proliferation of two gastrointestinal cancer cell lines. Prostaglandins Leukot. Essent. Fatty Acids, 55, 179-183.
31. Kawai,S. et al. (1998) Comparison of cyclooxygenase-1 and -2 inhibitory activities of various nonsteroidal anti-inflammatory drugs using human platelets and synovial cells. Eur. J. Pharmacol., 347, 87-94.
32. Tsutsumi,S. et al. (2002b) Gastric irritant-induced apoptosis in guinea pig gastric mucosal cells in primary culture. Biochim Biophys. Acta, 1589, 168-180.
33. Tanaka,K. et al. (2005) Involvement of intracellular Ca2+ levels in nonsteroidal anti-inflammatory drug-induced apoptosis. J. Biol. Chem., 280, 31059-31067.
34. Tomisato,W. et al. (2004a) Membrane permeabilization by non-steroidal anti-inflammatory drugs. Biochem Biophys. Res. Commun. 323, 1032-1039.
35. Tomisato,W. et al. (2004b) Role of direct cytotoxic effects of NSAIDs in the induction of gastric lesions. Biochem. Pharmacol., 67, 575-585.
36. Aung,P.P. (2006) Differntial expression of claudin-2 in normal human tissues and gastrointestinal carcinomas. Virchows Arch., 448 428-434.
37. Kinugasa,T. et al. (2007) Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res., 27, 3729-3734.
38. Gupta,R.A. et al. (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer, 1, 11-21.
39. Kismet, K. et al. (2004) Celecoxib: A potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect. Prev., 28, 127-142.